Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - BIOCRYST PHARMACEUTICALS INC | g22405e10vk.htm |
| EX-31.2 - EX-31.2 - BIOCRYST PHARMACEUTICALS INC | g22405exv31w2.htm |
| EX-31.1 - EX-31.1 - BIOCRYST PHARMACEUTICALS INC | g22405exv31w1.htm |
| EX-32.1 - EX-32.1 - BIOCRYST PHARMACEUTICALS INC | g22405exv32w1.htm |
| EX-10.33 - EX-10.33 - BIOCRYST PHARMACEUTICALS INC | g22405exv10w33.htm |
| EX-10.13 - EX-10.13 - BIOCRYST PHARMACEUTICALS INC | g22405exv10w13.htm |
| EX-10.16 - EX-10.16 - BIOCRYST PHARMACEUTICALS INC | g22405exv10w16.htm |
| EX-23 - EX-23 - BIOCRYST PHARMACEUTICALS INC | g22405exv23.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of BioCryst Pharmaceuticals, Inc. (the “Company”) on Form
10-K for the period ending December 31, 2009 as filed with the Securities and Exchange Commission
on the date hereof (the “Report”), I, Stuart Grant, Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
2002, that, to the best of my knowledge:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
| /s/ Stuart Grant | ||||
| Stuart Grant | ||||
| Chief Financial Officer March 9, 2010 |
||||
This certification is furnished with this Report on Form 10-K pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed
filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into
any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent
that the Company specifically incorporates it by reference.